School of Biosystems Engineering, University College Dublin, Belfield, Dublin 4, Ireland.
Environ Sci Process Impacts. 2013 Mar;15(3):617-22. doi: 10.1039/c2em30934c.
There is a concern that hospital effluent potentially containing antimicrobial compounds, antimicrobial resistant (AMR) bacteria and genetic determinants of resistance may contribute to the emergence, dissemination and persistence of AMR bacteria in municipal wastewaters. Hence, it is of interest to investigate the effect, if any, hospital effluent has on the percentage of AMR bacteria within wastewater. Water from two wastewater treatment plants (WWTPs) (one receives and treats hospital effluent (WWTPhe) and the second does not (WWTPc)) were examined for E. coli expressing resistance to seven antimicrobials (ampicillin, streptomycin, cefoxitin, cefotaxime, tetracycline, sulphonamide and ciprofloxacin). A two-sample t-test showed that AMR E. coli are present in WWTP influent and effluent, irrespective of receiving hospital effluent, and are being released into the environment (no statistical difference in count between the two WWTPs). The effect of hospital effluent on resistance varies for each AMR bacteria. Excluding tetracycline, sulphonamide and ciprofloxacin, the results suggest that the release of hospital effluent does not significantly affect the frequency with which AMR E. coli are detected in effluent. For some hospital specific antimicrobial agents, such as ciprofloxacin, the release of hospital effluent is associated with an increased proportion of antimicrobial resistance. The results suggest resistance to AMR E. coli may already be well developed in the community, making the effect of hospital effluent on AMR E. coli indistinguishable. However, for hospital specific antimicrobials, there may be a selective effect and hence limiting the release of hospital effluent containing such antimicrobials may impact the proportion of antimicrobial resistance. This research has provided statistical evidence to support necessary mitigation and remediation of antimicrobial residue release and subsequent resistance in the environment.
人们担心,含有抗菌化合物、抗药性(AMR)细菌和耐药性遗传因子的医院废水可能会导致 AMR 细菌在城市废水中出现、传播和持续存在。因此,研究医院废水对废水中 AMR 细菌比例的影响(如果有的话)是很有意义的。研究人员检查了来自两个污水处理厂(一个接收和处理医院废水(WWTPhe),另一个不接收(WWTPc))的水样,以确定表达对七种抗生素(氨苄青霉素、链霉素、头孢西丁、头孢噻肟、四环素、磺胺类药物和环丙沙星)耐药的大肠杆菌。双样本 t 检验显示,无论是否接收医院废水,AMR 大肠杆菌都存在于 WWTP 的进水和出水中,并被释放到环境中(两个 WWTP 之间的计数没有统计学差异)。医院废水对抗性的影响因每种 AMR 细菌而异。除了四环素、磺胺类药物和环丙沙星外,结果表明,医院废水的排放并没有显著影响在废水中检测到 AMR 大肠杆菌的频率。对于一些医院特有的抗菌剂,如环丙沙星,医院废水的排放与抗菌耐药性的比例增加有关。结果表明,社区中 AMR 大肠杆菌的耐药性可能已经得到了很好的发展,因此医院废水对 AMR 大肠杆菌的影响无法区分。然而,对于医院特有的抗菌药物,可能存在选择性效应,因此限制含有这些抗菌药物的医院废水的排放可能会影响抗菌耐药性的比例。本研究提供了统计证据,支持对环境中抗菌药物残留释放和随后的耐药性进行必要的缓解和修复。